![Douglas Drysdale](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Drysdale
Président chez
BETTERLIFE PHARMA INC.
Fortune : 181 704 $ au 30/06/2026
Profil
Douglas L.
Drysdale is currently Chief Executive Officer & Director at Pernix Manufacturing LLC, Chief Executive Officer at Cybin IRL Ltd., Executive Chairman at BetterLife Pharma, Inc. starting in 2026, Director at SpineThera, Inc. since 2022, and Director at Adelia Therapeutics, Inc. Former roles include Chief Executive Officer at Norwich Pharmaceuticals, Inc., Chairman, President & Chief Executive Officer at Pernix Therapeutics Holdings, Inc. from 2014 to 2016, Chief Executive Officer at Cybin, Inc. from 2020 to 2025, Chief Executive Officer at Alvogen Group, Inc. from 2008 to 2013, Chief Executive Officer at Clarmin Explorations, Inc., President & Chief Executive Officer at Tedor Pharma, Inc. from 2017 to 2020, Chief Executive Officer at Cybin Corp., Director at Cypress Pharmaceuticals, Inc., Principal at Forest Laboratories, Inc., Vice President at Zoetis Products LLC, Vice President-Mergers & Acquisitions at Actavis Group ehf from 2004 to 2008, and Executive Vice President-Corporate Development at Alkensa, Inc. Education includes an undergraduate degree from the University of East Anglia, conferred in 1992.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BETTERLIFE PHARMA INC. 0,99 % | 19/06/2026 | 1 608 000 ( 0,99 % ) | 181 704 $ | 30/06/2026 |
Postes actifs de Douglas Drysdale
| Sociétés | Poste | Début |
|---|---|---|
| BETTERLIFE PHARMA INC. | Président | 13/05/2026 |
Cybin IRL Ltd.
 Cybin IRL Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur Général | - |
SpineThera, Inc.
 SpineThera, Inc. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company that develops injectable drugs | Directeur/Membre du Conseil | 16/05/2022 |
Adelia Therapeutics, Inc.
 Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company | Directeur/Membre du Conseil | - |
Pernix Manufacturing LLC
 Pernix Manufacturing LLC Pharmaceuticals: MajorHealth Technology Manufactures special pharmaceutical products | Directeur Général | - |
Anciens postes connus de Douglas Drysdale
| Sociétés | Poste | Fin |
|---|---|---|
| CYBIN INC. | Directeur Général | 02/09/2025 |
Tedor Pharma, Inc.
 Tedor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and sales oral solid dose products | Directeur Général | 01/07/2020 |
| PERNIX THERAPEUTICS HOLDINGS INC | Directeur Général | 09/05/2016 |
Alvogen Group, Inc.
 Alvogen Group, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and distributes generic pharmaceutical products | Directeur Général | 01/10/2013 |
| ░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Douglas Drysdale
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
48
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
Zoetis Products LLC
 Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
BetterLife Pharma, Inc.
 BetterLife Pharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of therapeutic pharmaceutical products | Health Technology |
SpineThera, Inc.
SpineThera, Inc. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company that develops injectable drugs | Health Technology |
Actavis Group hf
 Actavis Group hf Pharmaceuticals: MajorHealth Technology Develops, manufactures and sales generic pharmaceuticals | Health Technology |
University of East Anglia
 University of East Anglia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cypress Pharmaceuticals, Inc.
 Cypress Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets, and distributes prescription products | Health Technology |
Norwich Pharmaceuticals, Inc.
 Norwich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides contract manufacturing and clinical services for the pharmaceuticals industry | Health Technology |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Alkensa, Inc. | |
Pernix Manufacturing LLC
Pernix Manufacturing LLC Pharmaceuticals: MajorHealth Technology Manufactures special pharmaceutical products | Health Technology |
Alvogen Group, Inc.
Alvogen Group, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and distributes generic pharmaceutical products | Health Technology |
Clarmin Explorations, Inc.
 Clarmin Explorations, Inc. Precious MetalsNon-Energy Minerals Provides metal and mineral mining services | Non-Energy Minerals |
Tedor Pharma, Inc.
Tedor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and sales oral solid dose products | Health Technology |
Cybin Corp.
 Cybin Corp. Medical DistributorsDistribution Services Provides psilocybin and carbohydrate products | Distribution Services |
Cybin, Inc.
 Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company | Health Technology |
Cybin IRL Ltd.
Cybin IRL Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Choisissez Zonebourse 
